BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barbara G, Feinle-Bisset C, Ghoshal UC, Quigley EM, Santos J, Vanner S, Vergnolle N, Zoetendal EG. The Intestinal Microenvironment and Functional Gastrointestinal Disorders. Gastroenterology. 2016;150:1305-1318. [PMID: 27144620 DOI: 10.1053/j.gastro.2016.02.028] [Cited by in Crossref: 134] [Cited by in F6Publishing: 103] [Article Influence: 22.3] [Reference Citation Analysis]
Number Citing Articles
1 Lacy BE, Pimentel M, Brenner DM, Chey WD, Keefer LA, Long MD, Moshiree B. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol 2021;116:17-44. [DOI: 10.14309/ajg.0000000000001036] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 23.5] [Reference Citation Analysis]
2 Simon E, Călinoiu LF, Mitrea L, Vodnar DC. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome. Nutrients 2021;13:2112. [PMID: 34203002 DOI: 10.3390/nu13062112] [Reference Citation Analysis]
3 Madempudi RS, Ahire JJ, Neelamraju J, Tripathi A, Nanal S. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. Sci Rep 2019;9:12210. [PMID: 31434935 DOI: 10.1038/s41598-019-48554-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
4 Fragkos KC, Keetarut K, Cox A, Eady J, Emmanuel AV, Zarate-Lopez N. Joint Hypermobility Syndrome Affects Response to a Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Irritable Bowel Syndrome Patients: A Retrospective Study. Gastroenterology Res 2019;12:27-36. [PMID: 30834032 DOI: 10.14740/gr1133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Defrees DN, Bailey J. Irritable Bowel Syndrome: Epidemiology, Pathophysiology, Diagnosis, and Treatment. Prim Care 2017;44:655-71. [PMID: 29132527 DOI: 10.1016/j.pop.2017.07.009] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
6 Lei S, Liu L, Ding L, Zhang Y, Zeng H. Lotus seed resistant starch affects the conversion of sodium taurocholate by regulating the intestinal microbiota. Int J Biol Macromol 2021;186:227-36. [PMID: 34245735 DOI: 10.1016/j.ijbiomac.2021.07.031] [Reference Citation Analysis]
7 Fan K, Talley NJ. Functional dyspepsia and duodenal eosinophilia: A new model: Dyspepsia and duodenal eosinophilia. Journal of Digestive Diseases 2017;18:667-77. [DOI: 10.1111/1751-2980.12556] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
8 Camilleri M, Oduyebo I, Halawi H. Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions. Am J Physiol Gastrointest Liver Physiol 2016;311:G777-84. [PMID: 27609770 DOI: 10.1152/ajpgi.00242.2016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
9 Lu WD, Wu ML, Zhang JX, Huang TT, Du SS, Cao YX. The effect of sodium carboxymethyl starch with high degree of substitution on defecation. PLoS One 2021;16:e0257012. [PMID: 34478474 DOI: 10.1371/journal.pone.0257012] [Reference Citation Analysis]
10 Kim GL, Yi YH, Hwang HR, Kim J, Park Y, Kim YJ, Lee JG, Tak YJ, Lee SH, Lee SY, Cho YH, Park EJ, Lee Y. The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database. J Clin Med 2021;10:2044. [PMID: 34068814 DOI: 10.3390/jcm10092044] [Reference Citation Analysis]
11 Barbara G, Cremon C, Azpiroz F. Probiotics in irritable bowel syndrome: Where are we? Neurogastroenterol Motil 2018;30:e13513. [DOI: 10.1111/nmo.13513] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
12 Pinto-sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin F, Cominetti O, Welsh C, Rieder A, Traynor J, Gregory C, De Palma G, Pigrau M, Ford AC, Macri J, Berger B, Bergonzelli G, Surette MG, Collins SM, Moayyedi P, Bercik P. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology 2017;153:448-459.e8. [DOI: 10.1053/j.gastro.2017.05.003] [Cited by in Crossref: 276] [Cited by in F6Publishing: 247] [Article Influence: 55.2] [Reference Citation Analysis]
13 Agah S, Akbari A, Heshmati J, Sepidarkish M, Morvaridzadeh M, Adibi P, Mazidi M, Farsi F, Ofori-asenso R, Talley NJ, Feinle-bisset C. Systematic review with meta-analysis: Effects of probiotic supplementation on symptoms in functional dyspepsia. Journal of Functional Foods 2020;68:103902. [DOI: 10.1016/j.jff.2020.103902] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Barbaro MR, Cremon C, Fuschi D, Scaioli E, Veneziano A, Marasco G, Festi D, Stanghellini V, Barbara G. Nerve fiber overgrowth in patients with symptomatic diverticular disease. Neurogastroenterol Motil 2019;31:e13575. [PMID: 30838745 DOI: 10.1111/nmo.13575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Desormeaux C, Bautzova T, Garcia-Caraballo S, Rolland C, Barbaro MR, Brierley SM, Barbara G, Vergnolle N, Cenac N. Protease-activated receptor 1 is implicated in irritable bowel syndrome mediators-induced signaling to thoracic human sensory neurons. Pain 2018;159:1257-67. [PMID: 29554016 DOI: 10.1097/j.pain.0000000000001208] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
16 Schmulson M, Ghoshal UC, Barbara G. Managing the Inevitable Surge of Post–COVID-19 Functional Gastrointestinal Disorders. Am J Gastroenterol 2021;116:4-7. [DOI: 10.14309/ajg.0000000000001062] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
17 Dahlgren D, Roos C, Lundqvist A, Tannergren C, Langguth P, Sjöblom M, Sjögren E, Lennernäs H. Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker 51Cr-EDTA. Mol Pharm 2017;14:4243-51. [PMID: 28737406 DOI: 10.1021/acs.molpharmaceut.7b00353] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
18 Ge X, Ding C, Zhao W, Xu L, Tian H, Gong J, Zhu M, Li J, Li N. Antibiotics-induced depletion of mice microbiota induces changes in host serotonin biosynthesis and intestinal motility. J Transl Med. 2017;15:13. [PMID: 28086815 DOI: 10.1186/s12967-016-1105-4] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 15.0] [Reference Citation Analysis]
19 Viganò D, Zara F, Usai P. Irritable bowel syndrome and endometriosis: New insights for old diseases. Digestive and Liver Disease 2018;50:213-9. [DOI: 10.1016/j.dld.2017.12.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
20 Rodiño-Janeiro BK, Vicario M, Alonso-Cotoner C, Pascua-García R, Santos J. A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies. Adv Ther 2018;35:289-310. [PMID: 29498019 DOI: 10.1007/s12325-018-0673-5] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 17.8] [Reference Citation Analysis]
21 Pensabene L, Salvatore S, D'Auria E, Parisi F, Concolino D, Borrelli O, Thapar N, Staiano A, Vandenplas Y, Saps M. Cow's Milk Protein Allergy in Infancy: A Risk Factor for Functional Gastrointestinal Disorders in Children? Nutrients 2018;10:E1716. [PMID: 30423934 DOI: 10.3390/nu10111716] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
22 Caputi V, Marsilio I, Cerantola S, Roozfarakh M, Lante I, Galuppini F, Rugge M, Napoli E, Giulivi C, Orso G, Giron MC. Toll-Like Receptor 4 Modulates Small Intestine Neuromuscular Function through Nitrergic and Purinergic Pathways. Front Pharmacol 2017;8:350. [PMID: 28642706 DOI: 10.3389/fphar.2017.00350] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
23 Meng Q, Qin G, Yao SK, Fan GH, Dong F, Tan C. Differences in dietary habits of people with vs without irritable bowel syndrome and their association with symptom and psychological status: A pilot study. World J Clin Cases 2021; 9(11): 2487-2502 [PMID: 33889614 DOI: 10.12998/wjcc.v9.i11.2487] [Reference Citation Analysis]
24 Zhu JJ, Su XL, Guo Y, Li YJ, Liu S, Wei W. Effect of physical exercises on chronic constipation and underlying mechanisms. Shijie Huaren Xiaohua Zazhi 2016; 24(20): 3159-3163 [DOI: 10.11569/wcjd.v24.i20.3159] [Reference Citation Analysis]
25 Simrén M, Törnblom H, Palsson OS, Van Oudenhove L, Whitehead WE, Tack J. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. Gastroenterology 2019;157:391-402.e2. [PMID: 31022401 DOI: 10.1053/j.gastro.2019.04.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
26 Bouzios I, Chouliaras G, Chrousos GP, Roma E, Gemou-Engesaeth V. Functional gastrointestinal disorders in Greek Children based on ROME III criteria: identifying the child at risk. Neurogastroenterol Motil. 2017;29. [PMID: 27679978 DOI: 10.1111/nmo.12951] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
27 Porsani MY, Paludetti M, Orlando DR, Peconick AP, Costa RC, Oliveira LE, Zangeronimo MG, Sousa RV. Protective effect of β-glucan and glutamine on intestinal and immunological damage in mice induced by cytarabine (Ara-C). Pesq Vet Bras 2017;37:977-83. [DOI: 10.1590/s0100-736x2017000900013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
28 Moussaoui N, Jacobs JP, Larauche M, Biraud M, Million M, Mayer E, Taché Y. Chronic Early-life Stress in Rat Pups Alters Basal Corticosterone, Intestinal Permeability, and Fecal Microbiota at Weaning: Influence of Sex. J Neurogastroenterol Motil 2017;23:135-43. [PMID: 27829577 DOI: 10.5056/jnm16105] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 10.4] [Reference Citation Analysis]
29 O'Brien R, O'Malley D. The Glucagon-like peptide-1 receptor agonist, exendin-4, ameliorated gastrointestinal dysfunction in the Wistar Kyoto rat model of Irritable Bowel Syndrome. Neurogastroenterol Motil 2020;32:e13738. [PMID: 31602785 DOI: 10.1111/nmo.13738] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Ghoshal UC, Ghoshal U. Investigations for dietary carbohydrate malabsorption and gut microbiota. Clinical and Basic Neurogastroenterology and Motility. Elsevier; 2020. pp. 359-70. [DOI: 10.1016/b978-0-12-813037-7.00025-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Singh R, Zogg H, Ro S. Role of microRNAs in Disorders of Gut-Brain Interactions: Clinical Insights and Therapeutic Alternatives. J Pers Med 2021;11:1021. [PMID: 34683162 DOI: 10.3390/jpm11101021] [Reference Citation Analysis]
32 Bajic JE, Johnston IN, Howarth GS, Hutchinson MR. From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation. Front Behav Neurosci 2018;12:104. [PMID: 29872383 DOI: 10.3389/fnbeh.2018.00104] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
33 Gracie DJ, Hamlin PJ, Ford AC. The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment. Lancet Gastroenterol Hepatol. 2019;4:632-642. [PMID: 31122802 DOI: 10.1016/s2468-1253(19)30089-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 23] [Article Influence: 16.0] [Reference Citation Analysis]
34 Di Nardo G, Cremon C, Frediani S, Lucarelli S, Villa MP, Stanghellini V, La Torre G, Martemucci L, Barbara G. Allergic Proctocolitis Is a Risk Factor for Functional Gastrointestinal Disorders in Children. The Journal of Pediatrics 2018;195:128-133.e1. [DOI: 10.1016/j.jpeds.2017.10.073] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
35 Halkjær SI, Christensen AH, Lo BZS, Browne PD, Günther S, Hansen LH, Petersen AM. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut 2018;67:2107-15. [PMID: 29980607 DOI: 10.1136/gutjnl-2018-316434] [Cited by in Crossref: 123] [Cited by in F6Publishing: 119] [Article Influence: 30.8] [Reference Citation Analysis]
36 Qiu JJ, Liu Z, Zhao P, Wang XJ, Li YC, Sui H, Owusu L, Guo HS, Cai ZX. Gut microbial diversity analysis using Illumina sequencing for functional dyspepsia with liver depression-spleen deficiency syndrome and the interventional Xiaoyaosan in a rat model. World J Gastroenterol 2017; 23(5): 810-816 [PMID: 28223725 DOI: 10.3748/wjg.v23.i5.810] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
37 . UEG Week 2018 Poster Presentations. United European Gastroenterol j 2018;6. [DOI: 10.1177/2050640618792819] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
38 Pisipati S, Connor BA, Riddle MS. Updates on the epidemiology, pathogenesis, diagnosis, and management of postinfectious irritable bowel syndrome. Curr Opin Infect Dis. 2020;33:411-418. [PMID: 32833689 DOI: 10.1097/qco.0000000000000666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Quigley EMM. Editorial: diet, inflammation and irritable bowel syndrome. Aliment Pharmacol Ther 2017;45:1278-9. [DOI: 10.1111/apt.14014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Dale HF, Rasmussen SH, Asiller ÖÖ, Lied GA. Probiotics in Irritable Bowel Syndrome: An Up-to-Date Systematic Review. Nutrients 2019;11:E2048. [PMID: 31480656 DOI: 10.3390/nu11092048] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
41 Hagiwara SI, Kaushal E, Paruthiyil S, Pasricha PJ, Hasdemir B, Bhargava A. Gastric corticotropin-releasing factor influences mast cell infiltration in a rat model of functional dyspepsia. PLoS One 2018;13:e0203704. [PMID: 30192883 DOI: 10.1371/journal.pone.0203704] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
42 Sinagra E, Morreale GC, Mohammadian G, Fusco G, Guarnotta V, Tomasello G, Cappello F, Rossi F, Amvrosiadis G, Raimondo D. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. World J Gastroenterol 2017; 23(36): 6593-6627 [PMID: 29085207 DOI: 10.3748/wjg.v23.i36.6593] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
43 Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017;11:196-208. [PMID: 28274108 DOI: 10.5009/gnl16126] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
44 Cristofori F, Tripaldi M, Lorusso G, Indrio F, Rutigliano V, Piscitelli D, Castellaneta S, Bentivoglio V, Francavilla R. Functional Abdominal Pain Disorders and Constipation in Children on Gluten-Free Diet. Clin Gastroenterol Hepatol 2020:S1542-3565(20)31229-5. [PMID: 32890754 DOI: 10.1016/j.cgh.2020.09.001] [Reference Citation Analysis]
45 Schmulson MJ, Drossman DA. What Is New in Rome IV. J Neurogastroenterol Motil. 2017;23:151-163. [PMID: 28274109 DOI: 10.5056/jnm16214] [Cited by in Crossref: 216] [Cited by in F6Publishing: 161] [Article Influence: 43.2] [Reference Citation Analysis]
46 Ma J, Li J, Qian M, He N, Cao Y, Liu Y, Wu K, He S. The comprehensive pathophysiological changes in a novel rat model of postinflammatory visceral hypersensitivity. FASEB J 2019;33:13560-71. [PMID: 31570003 DOI: 10.1096/fj.201901489R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
47 Thumann TA, Pferschy-Wenzig EM, Moissl-Eichinger C, Bauer R. The role of gut microbiota for the activity of medicinal plants traditionally used in the European Union for gastrointestinal disorders. J Ethnopharmacol 2019;245:112153. [PMID: 31408679 DOI: 10.1016/j.jep.2019.112153] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
48 Ghoshal UC. Marshall and Warren Lecture 2019: A paradigm shift in pathophysiological basis of irritable bowel syndrome and its implication on treatment. J Gastroenterol Hepatol 2020;35:712-21. [PMID: 32162356 DOI: 10.1111/jgh.15032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
49 Rahman MM, Mahadeva S, Ghoshal UC. Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review. World J Gastroenterol 2017; 23(37): 6788-6801 [PMID: 29085223 DOI: 10.3748/wjg.v23.i37.6788] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
50 Tuck CJ, Vanner SJ. Dietary therapies for functional bowel symptoms: Recent advances, challenges, and future directions. Neurogastroenterol Motil 2018;30:e13238. [DOI: 10.1111/nmo.13238] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
51 Ghoshal UC, Ghoshal U. Small Intestinal Bacterial Overgrowth and Other Intestinal Disorders. Gastroenterol Clin North Am. 2017;46:103-120. [PMID: 28164845 DOI: 10.1016/j.gtc.2016.09.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
52 Chey WD. Irritable Bowel Syndrome. Gastroenterol Clin North Am 2021;50:xv-xvi. [PMID: 34304798 DOI: 10.1016/j.gtc.2021.04.007] [Reference Citation Analysis]
53 Weaver KR, Melkus GD, Henderson WA. Irritable Bowel Syndrome. Am J Nurs 2017;117:48-55. [PMID: 28541989 DOI: 10.1097/01.NAJ.0000520253.57459.01] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
54 Ghoshal UC, Srivastava D, Misra A. A randomized double-blind placebo-controlled trial showing rifaximin to improve constipation by reducing methane production and accelerating colon transit: A pilot study. Indian J Gastroenterol 2018;37:416-23. [PMID: 30406392 DOI: 10.1007/s12664-018-0901-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
55 Ahluwalia B, Iribarren C, Magnusson MK, Sundin J, Clevers E, Savolainen O, Ross AB, Törnblom H, Simrén M, Öhman L. A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome. Cells 2021;10:1459. [PMID: 34200772 DOI: 10.3390/cells10061459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Reed DE, Vanner SJ. Emerging studies of human visceral nociceptors. Am J Physiol Gastrointest Liver Physiol 2017;312:G201-7. [PMID: 28007748 DOI: 10.1152/ajpgi.00391.2016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Corrigendum: Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:790387. [PMID: 34790692 DOI: 10.3389/fnut.2021.790387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Bayer SB, Gearry RB, Drummond LN. Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function. Crit Rev Food Sci Nutr 2018;58:2432-52. [PMID: 28557573 DOI: 10.1080/10408398.2017.1327841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
59 Wauters L, Burns G, Ceulemans M, Walker MM, Vanuytsel T, Keely S, Talley NJ. Duodenal inflammation: an emerging target for functional dyspepsia? Expert Opin Ther Targets 2020;24:511-23. [PMID: 32249629 DOI: 10.1080/14728222.2020.1752181] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
60 Ding JH, Jin Z, Yang XX, Lou J, Shan WX, Hu YX, Du Q, Liao QS, Xie R, Xu JY. Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World J Gastroenterol 2020; 26(40): 6141-6162 [PMID: 33177790 DOI: 10.3748/wjg.v26.i40.6141] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
61 Pretorius L, Smith C. The trace aminergic system: a gender-sensitive therapeutic target for IBS? J Biomed Sci 2020;27:95. [PMID: 32981524 DOI: 10.1186/s12929-020-00688-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Martoni CJ, Srivastava S, Leyer GJ. Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 Improve Abdominal Pain Severity and Symptomology in Irritable Bowel Syndrome: Randomized Controlled Trial. Nutrients 2020;12:E363. [PMID: 32019158 DOI: 10.3390/nu12020363] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
63 Yan Z, Yang M, Lai CL. Long COVID-19 Syndrome: A Comprehensive Review of Its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans. Biomedicines 2021;9:966. [PMID: 34440170 DOI: 10.3390/biomedicines9080966] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 13.0] [Reference Citation Analysis]
64 Du L, Shen J, Kim JJ, He H, Chen B, Dai N. Impact of gluten consumption in patients with functional dyspepsia: A case-control study. J Gastroenterol Hepatol. 2018;33:128-133. [PMID: 28452428 DOI: 10.1111/jgh.13813] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
65 Jin B, Singh R, Ha SE, Zogg H, Park PJ, Ro S. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19. World J Gastroenterol 2021; 27(19): 2341-2352 [PMID: 34040326 DOI: 10.3748/wjg.v27.i19.2341] [Reference Citation Analysis]
66 Kumari MV, Amarasiri L, Rajindrajith S, Devanarayana NM. Functional abdominal pain disorders and asthma: two disorders, but similar pathophysiology? Expert Rev Gastroenterol Hepatol 2021;15:9-24. [PMID: 32909837 DOI: 10.1080/17474124.2020.1821652] [Reference Citation Analysis]
67 Fukui H, Xu X, Miwa H. Role of Gut Microbiota-Gut Hormone Axis in the Pathophysiology of Functional Gastrointestinal Disorders. J Neurogastroenterol Motil 2018;24:367-86. [PMID: 29969855 DOI: 10.5056/jnm18071] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
68 Dong Y, Baumeister D, Berens S, Eich W, Tesarz J. High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care. Front Psychiatry 2019;10:714. [PMID: 31681031 DOI: 10.3389/fpsyt.2019.00714] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
69 Bajaj JS, Barbara G, DuPont HL, Mearin F, Gasbarrini A, Tack J. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Dig Liver Dis 2018;50:741-9. [PMID: 29807873 DOI: 10.1016/j.dld.2018.04.020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
70 Mizuno S, Masaoka T, Naganuma M, Kishimoto T, Kitazawa M, Kurokawa S, Nakashima M, Takeshita K, Suda W, Mimura M, Hattori M, Kanai T. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. Digestion 2017;96:29-38. [PMID: 28628918 DOI: 10.1159/000471919] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 11.2] [Reference Citation Analysis]
71 Porcelli P, De Carne M, Leandro G. Distinct associations of DSM-5 Somatic Symptom Disorder, the Diagnostic Criteria for Psychosomatic Research-Revised (DCPR-R) and symptom severity in patients with irritable bowel syndrome. Gen Hosp Psychiatry 2020;64:56-62. [PMID: 32199282 DOI: 10.1016/j.genhosppsych.2020.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Hajishafiee M, Bitarafan V, Feinle-Bisset C. Gastrointestinal Sensing of Meal-Related Signals in Humans, and Dysregulations in Eating-Related Disorders. Nutrients 2019;11:E1298. [PMID: 31181734 DOI: 10.3390/nu11061298] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
73 Quigley EMM. Prebiotics and Probiotics in Digestive Health. Clin Gastroenterol Hepatol. 2019;17:333-344. [PMID: 30267869 DOI: 10.1016/j.cgh.2018.09.028] [Cited by in Crossref: 77] [Cited by in F6Publishing: 58] [Article Influence: 19.3] [Reference Citation Analysis]
74 Lee KJ. The Usefulness of Symptom-based Subtypes of Functional Dyspepsia for Predicting Underlying Pathophysiologic Mechanisms and Choosing Appropriate Therapeutic Agents. J Neurogastroenterol Motil 2021;27:326-36. [PMID: 34210898 DOI: 10.5056/jnm21042] [Reference Citation Analysis]
75 Aoyama T, Fukumoto A, Shigita K, Asayama N, Mukai S, Nagata S. Bile pigment in small-bowel water content may reflect bowel habits: a retrospective analysis of a capsule endoscopy imaging series. BMC Gastroenterol 2020;20:237. [PMID: 32703159 DOI: 10.1186/s12876-020-01382-0] [Reference Citation Analysis]
76 Canakis A, Haroon M, Weber HC. Irritable bowel syndrome and gut microbiota. Current Opinion in Endocrinology, Diabetes & Obesity 2020;27:28-35. [DOI: 10.1097/med.0000000000000523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
77 Gwee KA, Gonlachanvit S, Ghoshal UC, Chua ASB, Miwa H, Wu J, Bak YT, Lee OY, Lu CL, Park H, Chen M, Syam AF, Abraham P, Sollano J, Chang CS, Suzuki H, Fang X, Fukudo S, Choi MG, Hou X, Hongo M. Second Asian Consensus on Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2019;25:343-362. [PMID: 31327218 DOI: 10.5056/jnm19041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
78 Singh R, Zogg H, Wei L, Bartlett A, Ghoshal UC, Rajender S, Ro S. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders.J Neurogastroenterol Motil. 2021;27:19-34. [PMID: 33166939 DOI: 10.5056/jnm20149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
79 Quigley EMM. Low FODMAP (fermentable oligo-, di-, monosaccharides, and polyol) diet goes global. Am J Clin Nutr 2021;113:1394-5. [PMID: 33851195 DOI: 10.1093/ajcn/nqab084] [Reference Citation Analysis]
80 Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology. 2016;150:1257-1261. [PMID: 27147121 DOI: 10.1053/j.gastro.2016.03.035] [Cited by in Crossref: 462] [Cited by in F6Publishing: 365] [Article Influence: 115.5] [Reference Citation Analysis]
81 Zhou W, Chen Y, Roh T, Lin Y, Ling S, Zhao S, Lin JD, Khalil N, Cairns DM, Manousiouthakis E, Tse M, Kaplan DL. Multifunctional Bioreactor System for Human Intestine Tissues. ACS Biomater Sci Eng 2018;4:231-9. [PMID: 29333491 DOI: 10.1021/acsbiomaterials.7b00794] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
82 De Filippis A, Ullah H, Baldi A, Dacrema M, Esposito C, Garzarella EU, Santarcangelo C, Tantipongpiradet A, Daglia M. Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment. Int J Mol Sci 2020;21:E4929. [PMID: 32668581 DOI: 10.3390/ijms21144929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
83 Chey WD, Whelan K. Dietary guidelines for irritable bowel syndrome are important for gastroenterologists, dietitians and people with irritable bowel syndrome. J Hum Nutr Diet 2016;29:547-8. [PMID: 27599641 DOI: 10.1111/jhn.12413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
84 Greenwood-Van Meerveld B, Johnson AC. Stress-Induced Chronic Visceral Pain of Gastrointestinal Origin. Front Syst Neurosci 2017;11:86. [PMID: 29213232 DOI: 10.3389/fnsys.2017.00086] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
85 Oświęcimska J, Szymlak A, Roczniak W, Girczys-Połedniok K, Kwiecień J. New insights into the pathogenesis and treatment of irritable bowel syndrome. Adv Med Sci 2017;62:17-30. [PMID: 28135659 DOI: 10.1016/j.advms.2016.11.001] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 11.0] [Reference Citation Analysis]
86 Ghoshal UC. Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros. J Neurogastroenterol Motil. 2017;23:334-340. [PMID: 28672432 DOI: 10.5056/jnm17020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
87 Malnick SDH, Fisher D, Somin M, Neuman MG. Treating the Metabolic Syndrome by Fecal Transplantation-Current Status. Biology (Basel) 2021;10:447. [PMID: 34065241 DOI: 10.3390/biology10050447] [Reference Citation Analysis]
88 Ha S, Jin B, Clemmensen B, Park P, Mahboob S, Gladwill V, Lovely FM, Gottfried-Blackmore A, Habtezion A, Verma S, Ro S. Serotonin is elevated in COVID-19-associated diarrhoea. Gut. 2021;epub ahead of print. [PMID: 33402416 DOI: 10.1136/gutjnl-2020-323542] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
89 Cui J, Lin Z, Tian H, Yang B, Zhao D, Ye C, Li N, Qin H, Chen Q. Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study. Front Med (Lausanne) 2021;8:710452. [PMID: 34395484 DOI: 10.3389/fmed.2021.710452] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Navarro F, Liu Y, Rhoads JM. Can probiotics benefit children with autism spectrum disorders? World J Gastroenterol 2016; 22(46): 10093-10102 [PMID: 28028357 DOI: 10.3748/wjg.v22.i46.10093] [Cited by in CrossRef: 68] [Cited by in F6Publishing: 50] [Article Influence: 11.3] [Reference Citation Analysis]
91 Chey WD, Keefer L, Whelan K, Gibson PR. Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome. Gastroenterology 2021;160:47-62. [PMID: 33091411 DOI: 10.1053/j.gastro.2020.06.099] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
92 Bhattarai Y, Muniz Pedrogo DA, Kashyap PC. Irritable bowel syndrome: a gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol. 2017;312:G52-G62. [PMID: 27881403 DOI: 10.1152/ajpgi.00338.2016] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 12.5] [Reference Citation Analysis]
93 Cremon C, Stanghellini V, Barbaro MR, Cogliandro RF, Bellacosa L, Santos J, Vicario M, Pigrau M, Alonso Cotoner C, Lobo B, Azpiroz F, Bruley des Varannes S, Neunlist M, DeFilippis D, Iuvone T, Petrosino S, Di Marzo V, Barbara G. Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome. Aliment Pharmacol Ther. 2017;45:909-922. [PMID: 28164346 DOI: 10.1111/apt.13958] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
94 Wongtrakul W, Charoenngam N, Ungprasert P. The association between irritable bowel syndrome and osteoporosis: a systematic review and meta-analysis. Osteoporos Int 2020;31:1049-57. [PMID: 32008157 DOI: 10.1007/s00198-020-05318-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
95 Tziatzios G, Gkolfakis P, Papanikolaou IS, Mathur R, Pimentel M, Giamarellos-Bourboulis EJ, Triantafyllou K. Gut Microbiota Dysbiosis in Functional Dyspepsia. Microorganisms 2020;8:E691. [PMID: 32397332 DOI: 10.3390/microorganisms8050691] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
96 Xiao L, Liu Q, Luo M, Xiong L. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome. Front Cell Infect Microbiol 2021;11:729346. [PMID: 34631603 DOI: 10.3389/fcimb.2021.729346] [Reference Citation Analysis]
97 Colomier E, Algera J, Melchior C. Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea. Front Pharmacol 2020;11:629026. [PMID: 33679391 DOI: 10.3389/fphar.2020.629026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Tziatzios G, Giamarellos-bourboulis EJ, Papanikolaou IS, Pimentel M, Dimitriadis GD, Triantafyllou K. Is small intestinal bacterial overgrowth involved in the pathogenesis of functional dyspepsia? Medical Hypotheses 2017;106:26-32. [DOI: 10.1016/j.mehy.2017.07.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
99 Wang MC, Zaydi AI, Lin WH, Lin JS, Liong MT, Wu JJ. Putative Probiotic Strains Isolated from Kefir Improve Gastrointestinal Health Parameters in Adults: a Randomized, Single-Blind, Placebo-Controlled Study. Probiotics Antimicrob Proteins 2020;12:840-50. [PMID: 31749128 DOI: 10.1007/s12602-019-09615-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
100 Walker MM, Talley NJ. The Role of Duodenal Inflammation in Functional Dyspepsia. Journal of Clinical Gastroenterology 2017;51:12-8. [DOI: 10.1097/mcg.0000000000000740] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 4.8] [Reference Citation Analysis]
101 Simrén M, Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol 2018;15:589-605. [PMID: 29930260 DOI: 10.1038/s41575-018-0034-5] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 17.0] [Reference Citation Analysis]
102 Barbara G, Barbaro MR, Fuschi D, Palombo M, Falangone F, Cremon C, Marasco G, Stanghellini V. Inflammatory and Microbiota-Related Regulation of the Intestinal Epithelial Barrier. Front Nutr 2021;8:718356. [PMID: 34589512 DOI: 10.3389/fnut.2021.718356] [Reference Citation Analysis]
103 Koduru P, Irani M, Quigley EMM. Definition, Pathogenesis, and Management of That Cursed Dyspepsia. Clin Gastroenterol Hepatol 2018;16:467-79. [PMID: 28899670 DOI: 10.1016/j.cgh.2017.09.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
104 Quigley EMM. The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS). J Clin Med 2018;7:E6. [PMID: 29301380 DOI: 10.3390/jcm7010006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
105 Skonieczna-Żydecka K, Stachowska E, Maciejewska D, Ryterska K, Palma J, Czerwińska-Rogowska M, Kaczmarczyk M, Gudan A, Mruk H, Świniarska B, Kałduńska J, Stachowska Z, Mijal P, Mazur T, Kupczyński M, Marlicz W. The Digestive Health among Participants of the Woodstock Rock Festival in Poland-A Cross-Sectional Survey. Int J Environ Res Public Health 2018;15:E2256. [PMID: 30326654 DOI: 10.3390/ijerph15102256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
106 Xu Y, Bai T, Xiong Y, Liu C, Liu Y, Hou X, Song J. Mechanical stimulation activates Piezo1 to promote mucin2 expression in goblet cells. J Gastroenterol Hepatol 2021. [PMID: 34169583 DOI: 10.1111/jgh.15596] [Reference Citation Analysis]
107 Luo L, Hu M, Li Y, Chen Y, Zhang S, Chen J, Wang Y, Lu B, Xie Z, Liao Q. Association between metabolic profile and microbiomic changes in rats with functional dyspepsia. RSC Adv 2018;8:20166-81. [DOI: 10.1039/c8ra01432a] [Cited by in Crossref: 17] [Article Influence: 4.3] [Reference Citation Analysis]
108 Barbalho SM, Goulart RA, Araújo AC, Guiguer ÉL, Bechara MD. Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D. Expert Rev Gastroenterol Hepatol 2019;13:345-59. [PMID: 30791775 DOI: 10.1080/17474124.2019.1570137] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]